RYAN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ryan Specialty Holdings Inc is not a strong buy at the moment for a beginner investor with a long-term perspective. The stock's pre-market price of $35.4 is below most analyst price targets, but the financial performance shows significant declines in net income and EPS. Additionally, the technical indicators and options data do not suggest a strong bullish sentiment. While hedge funds are buying, the lack of significant insider activity and the mixed analyst ratings indicate a cautious approach is warranted.
The MACD histogram is positive at 0.393, indicating a bullish trend, but it is contracting, suggesting weakening momentum. The RSI is neutral at 39.13, and moving averages are converging, showing no clear trend. Key support is at $34.514, and resistance is at $38.143, with the current price near support levels.
Hedge funds are significantly increasing their positions in the stock, with a 53579.79% increase in buying activity. Vulcan Value Partners initiated a position in Ryan Specialty, indicating institutional interest.
The company's Q4 2025 financials show a 47.13% YoY drop in net income and a 111.76% YoY drop in EPS, reflecting poor profitability. Analyst ratings are mixed, with multiple firms lowering price targets and expressing concerns about pricing pressures and sluggish growth in the insurance sector.
In Q4 2025, revenue grew 13.21% YoY to $751.2 million, but net income dropped 47.13% YoY to $7.98 million, and EPS fell 111.76% YoY to $0.06. Gross margin remained unchanged.
Analyst ratings are mixed. While some firms maintain Buy ratings with price targets above the current price, others have downgraded to Neutral or Underweight, citing pricing pressures, sluggish growth, and sector challenges.
